Sign in
4/A

Changes in Ownership

BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001104659-24-084341

President & CEO bought 40,000 shares at an average $0.47 ($18,865)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Lebovits Chaim President & CEO 2024-05-10 Purchase +20,000 $0.47 $9,300 1,079,865 D
Lebovits Chaim President & CEO 2024-05-11 Purchase +10,000 $0.47 $4,665 1,089,865 D
Lebovits Chaim President & CEO 2024-05-13 Purchase +10,000 $0.49 $4,900 1,099,865 D
Open-market purchases · 40,000 sh · avg $0.47 · $18,865
Loading xslF345X05/tm2420560-5_4aseq1.xml…